Abstract
The rise of carbapenem-resistant Klebsiella pneumoniae (CRKP) represents a significant global health threat, necessitating rapid diagnostic tools to guide clinical intervention. Traditional antimicrobial susceptibility testing (AST) often requires 18–24 hours, a delay that can be fatal in cases of sepsis. This paper details a rapid phenotypic method using automated flow cytometry (AFC) to identify susceptibility-associated signatures in bacterial populations within hours. By monitoring changes in cell size, count, and DNA staining, researchers can distinguish between sensitive and resistant strains significantly faster than culture-based methods.
Introduction
Klebsiella pneumoniae is a primary driver of healthcare-associated infections. When these bacteria develop resistance to carbapenems—often the last line of defense—treatment options become severely limited. The clinical challenge is not just the resistance itself, but the time required to detect it. Phenotypic tests that observe the actual behavior of bacteria in the presence of antibiotics offer a more direct measure of efficacy than genotypic tests, which may detect resistance genes that are not being expressed.
Methodology: Automated Flow Cytometry and Gating
The core of this rapid profiling method is Automated Flow Cytometry (AFC) combined with fluorescent staining. Bacteria are treated with SYTO 9, a green-fluorescent nucleic acid stain. To ensure the data reflects viable individual cells rather than debris or artifacts, a rigorous gating strategy is employed.
As shown in the gating workflow, the process involves four primary steps:
- Ungated Data: Initial capture of all events.
- Cell Events: Filtering based on SYTO 9 fluorescence to identify DNA-containing particles.
- Doublet Removal: Using forward scatter (FSC) area vs. height to exclude cell clumps.
- Background Removal: Final cleanup using unused fluorescence channels to eliminate non-bacterial signals.
The Susceptibility-Associated Signature
Once the data is cleaned, researchers look for a "susceptibility-associated signature." This signature is defined by three primary metrics:
- Forward Scatter (FSC): Indicates changes in cell size or morphology (e.g., elongation due to stress).
- Fluorescence Intensity: Reflects changes in how the SYTO 9 stain interacts with the cell membrane and nucleic acids.
- Event Counts: The total number of detected cells, indicating population growth or decline.
In susceptible strains, exposure to meropenem at or above the Minimum Inhibitory Concentration (MIC) triggers a predictable transformation. Initially, cells may show increased size and fluorescence as they undergo stress, followed by a breakdown into low-fluorescence debris.
Results and Discussion
The study validated this approach using well-characterized susceptible strains (ATCC 700603) and highly resistant clinical isolates (Strain K8).
A key finding was the use of contouring to visualize population shifts. For susceptible strains, a distinct shift in the population was visible at concentrations as low as 0.25 mg/L. At higher concentrations (32x MIC), the population fractured into distinct "contouring foci," representing various stages of cell degradation. Conversely, resistant strains showed virtually no change in their flow cytometry plots, appearing identical to untreated controls even at high antibiotic concentrations.
Conclusion
By leveraging the speed of flow cytometry and the precision of automated gating, this method provides a rapid alternative to traditional AST. While further validation across a broader range of clinical isolates and resistance mechanisms is needed, the ability to detect phenotypic susceptibility within 2–4 hours marks a significant step forward in the management of carbapenem-resistant infections.
Summary updated